Guidelines for the welfare and use of animals in cancer researchPaul Workman, Sue Eccles|British Journal of Cancer|2010Cited by 1.4k
Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesSwen Hoelder, Paul Workman|Molecular Oncology|2012Cited by 581
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsMartin O. Leach, Paul Workman|British Journal of Cancer|2005Cited by 513
New approaches to molecular cancer therapeuticsIan Collins, Paul Workman|Nature Chemical Biology|2006Cited by 387
The Cyclin-dependent Kinase Inhibitor CYC202 (<b><i>R</i></b>-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase PathwaySteven R. Whittaker, Paul Workman|Cancer Research|2004Cited by 194